cas 1668-86-6|| where to buy (+/-)-Narwedine

Название продукции:(+/-)-Narwedine

IUPAC Name:(1S,12S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-one

Упаковочная единица	Доступно для заказа	Цена ($)
CM244272-250mg	in stock	ɐɐ
CM244272-1g	in stock	ȦƱƋ
CM244272-5g	in stock	ɐǕȦ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1668-86-6 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:1668-86-6; Молекулярная формула:C17H19NO3; Точка плавления:-; Smiles-код:O=C1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24; Плотность:

: Номер в каталоге:CM244272; Молекулярная масса:285.34; Точка кипения:; Номер Mdl:MFCD13193038; Хранение:

: ZUNVEYL; Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.